» Articles » PMID: 31546931

Fumonisins at Doses Below EU Regulatory Limits Induce Histological Alterations in Piglets

Overview
Journal Toxins (Basel)
Publisher MDPI
Specialty Toxicology
Date 2019 Sep 25
PMID 31546931
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Fumonisins (FBs) are mycotoxins produced by species that can contaminate human food and animal feed. Due to the harmful effects of FBs on animals, the European Union (EU) defined a recommendation of a maximum of 5 mg FBs (B1 + B2)/kg for complete feed for swine and 1 µg FBs/kg body weight per day as the tolerable daily intake for humans. The aim of this study was to evaluate the toxicity of dietary exposure to low doses of FBs, including a dose below the EU regulatory limits. Four groups of 24 weaned castrated male piglets were exposed to feed containing 0, 3.7, 8.1, and 12.2 mg/kg of FBs for 28 days; the impact was measured by biochemical analysis and histopathological observations. Dietary exposure to FBs at a low dose (3.7 mg/kg of feed) significantly increased the plasma sphinganine-to-sphingosine ratio. FBs-contaminated diets led to histological modifications in the intestine, heart, lung, lymphoid organs, kidney, and liver. The histological alterations in the heart and the intestine appeared at the lowest dose of FBs-contaminated diet (3.7 mg/kg feed) and in the kidney at the intermediate dose (8.1 mg/kg feed). At the highest dose tested (12.2 mg/kg feed), all the organs displayed histological alterations. This dose also induced biochemical modifications indicative of kidney and liver alterations. In conclusion, our data indicate that FBs-contaminated diets at doses below the EU regulatory limit cause histological lesions in several organs. This study suggests that EU recommendations for the concentration of FBs in animal feed, especially for swine, are not sufficiently protective and that regulatory doses should be modified for better protection of animal health.

Citing Articles

Biomarkers of Fumonisin Exposure in Pigs Fed the Maximum Recommended Level in Europe.

Lassallette E, Pierron A, Tardieu D, Reymondaud S, Gallissot M, Rodriguez M Toxins (Basel). 2025; 17(2).

PMID: 39998086 PMC: 11861712. DOI: 10.3390/toxins17020069.


Sensitive ratiometric detection of Fumonisin B using a reusable Ag-pSi SERS platform.

Nirala N, Sadhasivam S, Kumar Singh R, Sionov E, Shtenberg G Food Chem X. 2025; 25():102151.

PMID: 39850046 PMC: 11754687. DOI: 10.1016/j.fochx.2024.102151.


A Review of the Mycotoxin Family of Fumonisins, Their Biosynthesis, Metabolism, Methods of Detection and Effects on Humans and Animals.

Anumudu C, Ekwueme C, Uhegwu C, Ejileugha C, Augustine J, Okolo C Int J Mol Sci. 2025; 26(1.

PMID: 39796041 PMC: 11719890. DOI: 10.3390/ijms26010184.


Comparison Study of Two Fumonisin-Degrading Enzymes for Detoxification in Piglets.

Wang Z, Lv Z, Czabany T, Nagl V, Krska R, Wang X Toxins (Basel). 2024; 16(1).

PMID: 38276527 PMC: 10819594. DOI: 10.3390/toxins16010003.


Modulation of Broiler Intestinal Changes Induced by and Deoxynivalenol through Probiotic, Paraprobiotic, and Postbiotic Supplementation.

de Souza M, Baptista A, Menck-Costa M, Justino L, da Gloria E, Shimizu G Toxins (Basel). 2024; 16(1).

PMID: 38251262 PMC: 10820081. DOI: 10.3390/toxins16010046.


References
1.
Knutsen H, Barregard L, Bignami M, Bruschweiler B, Ceccatelli S, Cottrill B . Appropriateness to set a group health-based guidance value for fumonisins and their modified forms. EFSA J. 2020; 16(2):e05172. PMC: 7009576. DOI: 10.2903/j.efsa.2018.5172. View

2.
Bracarense A, Lucioli J, Grenier B, Drociunas Pacheco G, Moll W, Schatzmayr G . Chronic ingestion of deoxynivalenol and fumonisin, alone or in interaction, induces morphological and immunological changes in the intestine of piglets. Br J Nutr. 2011; 107(12):1776-86. DOI: 10.1017/S0007114511004946. View

3.
Raichur S, Wang S, Chan P, Li Y, Ching J, Chaurasia B . CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab. 2014; 20(4):687-95. DOI: 10.1016/j.cmet.2014.09.015. View

4.
Burel C, Tanguy M, Guerre P, Boilletot E, Cariolet R, Queguiner M . Effect of low dose of fumonisins on pig health: immune status, intestinal microbiota and sensitivity to Salmonella. Toxins (Basel). 2013; 5(4):841-64. PMC: 3705294. DOI: 10.3390/toxins5040841. View

5.
Helke K, Swindle M . Animal models of toxicology testing: the role of pigs. Expert Opin Drug Metab Toxicol. 2012; 9(2):127-39. DOI: 10.1517/17425255.2013.739607. View